Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001490131 | SCV001694689 | likely benign | Tuberous sclerosis 2 | 2022-02-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002346136 | SCV002640785 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |